Literature DB >> 10694802

Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity.

H Jonuleit1, T Tüting, J Steitz, J Brück, A Giesecke, K Steinbrink, J Knop, A H Enk.   

Abstract

We have developed a culture method for the foreign serum-free generation of highly immunostimulatory, CD83+ human dendritic cells (DC). In this study, we evaluated the feasibility and consequences of endogenously expressing antigens in mature DC using adenoviral vectors. Transduction of DC with Ad-EGFP demonstrated endogenous fluorescence in 50-85% of CD83+ DC. Ad-transduced DC stimulated the proliferation of allogeneic CD8+ and CD4+ T cells at low DC: T cell ratios. However, at high DC: T cell ratios the stimulatory capacity of Ad-transduced DC was suppressed. This immunosuppressive effect was confirmed by demonstrating that the stimulatory function of untreated DC could be suppressed in a dose-dependent manner by addition of Ad-transduced DC. Furthermore, transwell experiments suggested that direct cell contact was required. Taken together, our results demonstrate the feasibility of efficiently expressing antigens in CD83+ DC using adenoviruses. However, immunosuppressive effects must be considered and carefully studied before Ad-transduced DC are employed for clinical trials. Gene Therapy (2000) 7, 249-254.

Entities:  

Mesh:

Year:  2000        PMID: 10694802     DOI: 10.1038/sj.gt.3301077

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  11 in total

1.  Comparative analysis of transduced primary human dendritic cells generated by the use of three different lentiviral vector systems.

Authors:  Elena Grabski; Zoe Waibler; Silke Schüle; Björn-Philipp Kloke; Linda Y Sender; Sylvia Panitz; Klaus Cichutek; Matthias Schweizer; Ulrich Kalinke
Journal:  Mol Biotechnol       Date:  2011-03       Impact factor: 2.695

2.  Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2.

Authors:  Allison T Thiele; Tina L Sumpter; Joanna A Walker; Qi Xu; Cheong-Hee Chang; Robert L Bacallao; Rajesh Kher; David S Wilkes
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway.

Authors:  A E Morelli; A T Larregina; R W Ganster; A F Zahorchak; J M Plowey; T Takayama; A J Logar; P D Robbins; L D Falo; A W Thomson
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Human dendritic cells infected with an adenoviral vector suppress proliferation of autologous and allogeneic T cells.

Authors:  Katy R Newton; Emma Sala-Soriano; Hemlata Varsani; John R Stephenson; David Goldblatt; Lucy R Wedderburn
Journal:  Immunology       Date:  2008-05-28       Impact factor: 7.397

5.  Construction of HA-1-DC nucleic-acid vaccine and induction of specific cytotoxic T lymphocytes.

Authors:  Yaya Wang; Donghua Zhang; Jinmei Hu; Wenli Liu; Hongsheng Zhou; Lu Zhang; Dan Liu; Zhenqian Huang; Huo Tan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-06

6.  Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.

Authors:  H Jonuleit; E Schmitt; M Stassen; A Tuettenberg; J Knop; A H Enk
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

7.  In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin.

Authors:  Hoe Suk Kim; Jisu Woo; Jae Hoon Lee; Hyun Jung Joo; YoonSeok Choi; Hyeonjin Kim; Woo Kyung Moon; Seung Ja Kim
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

8.  Targeting CD83 for the treatment of graft-versus-host disease.

Authors:  Xiongfei Wang; Ming Q Wei; Xiaosong Liu
Journal:  Exp Ther Med       Date:  2013-04-02       Impact factor: 2.447

9.  In vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes.

Authors:  Juan Sebastián Pappalardo; Cecilia A Langellotti; Sebastián Di Giacomo; Valeria Olivera; Valeria Quattrocchi; Patricia I Zamorano; William C Hartner; Tatyana S Levchenko; Vladimir P Torchilin
Journal:  Int J Nanomedicine       Date:  2014-02-13

10.  Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors.

Authors:  Q F Sun; X N Zhao; C L Peng; Y T Hao; Y P Zhao; N Jiang; H Xue; J Z Guo; C H Yun; B Cong; X G Zhao
Journal:  Oncol Rep       Date:  2015-08-27       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.